Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder

BACKGROUND: Recent clinical trials indicate that pharmacogenetic-guided treatment of major depressive disorder (MDD) results in higher treatment response rates by genetically matching patients to medications and avoiding a trial-and-error process. OBJECTIVE: To evaluate the cost-effectiveness of a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Groessl, Erik J., Tally, Steven R., Hillery, Naomi, Maciel, Alejandra, Garces, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397625/
https://www.ncbi.nlm.nih.gov/pubmed/30058980
http://dx.doi.org/10.18553/jmcp.2018.24.8.726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397625/
https://www.ncbi.nlm.nih.gov/pubmed/30058980
http://dx.doi.org/10.18553/jmcp.2018.24.8.726

Ejemplares similares